Betamethasone latency period and neonatal hypoglycemia in term infants
In this cohort of term infants, a shorter latency period between BMZ administration and delivery was not associated with increased incidence or treatment of hypoglycemia. However, the rate of hypoglycemia screening was low in both groups and rates of undiagnosed hypoglycemia in BMZ-exposed term neonates remain unknown. Prospective longitudinal studies aimed at characterizing the risk of hypoglycemia in term infants exposed to BMZ would be beneficial to inform hypoglycemia screening practices in BMZ-exposed neonates.
Authors
- Connor Demorest (ORCID: https://orcid.org/0000-0002-3054-6288)
- Sarah A. Wernimont (ORCID: https://orcid.org/0000-0002-6894-7837)
- Raghavendra Rao (ORCID: https://orcid.org/0000-0002-6089-5972)
- Katelyn Tessier (ORCID: https://orcid.org/0000-0002-5513-583X)
- Briana Clifton (ORCID: https://orcid.org/0000-0002-3820-8611)
- Lauren A. Buckley
Institutions
- University of Minnesota (US)
- Cancer Research And Biostatistics (US)
Publication Details
- Journal
- The Journal of Maternal-Fetal & Neonatal Medicine
- Published
- 2025-08-03
- DOI
- https://doi.org/10.1080/14767058.2025.2540477
- Citations
- 1
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Clinical and Translational Science Institute, University of Minnesota
- National Center for Advancing Translational Sciences